Literature DB >> 18815305

Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Zhili Xu1, Jie Tian, Jeffrey S Smith, Andrew P Byrnes.   

Abstract

Kupffer cells (KCs) rapidly remove intravenously injected adenovirus (Ad) vectors from the circulation. A better understanding of the mechanisms involved could suggest strategies to improve Ad gene delivery by suppressing or evading KC uptake. We recently showed that clearance of Ad type 5 vectors by KCs does not involve the interaction of Ad with the well-established Ad receptors, namely, integrins or the coxsackievirus and Ad receptor (J. S. Smith, Z. Xu, J. Tian, S. C. Stevenson, and A. P. Byrnes, Hum. Gene Ther. 19:547-554, 2008). In the current study, we systematically quantified the contributions of various receptors and plasma proteins to the clearance of Ad by KCs. We found that scavenger receptors are a predominant mechanism for the clearance of Ad by KCs. In addition, we found that Ad is opsonized by natural immunoglobulin M antibodies and complement and that these opsonins play a contributory role in the clearance of Ad by KCs. We also examined additional mechanisms that have been postulated to be involved in the clearance of Ad, including the binding of Ad to platelets and vitamin K-dependent coagulation factors, but we found that neither of these were required for the clearance of Ad by KCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815305      PMCID: PMC2583672          DOI: 10.1128/JVI.01320-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

Authors:  Y Zhang; N Chirmule; G P Gao; R Qian; M Croyle; B Joshi; J Tazelaar; J M Wilson
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

2.  Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures.

Authors:  N Kobayashi; T Kuramoto; K Yamaoka; M Hashida; Y Takakura
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

3.  Morphological studies of the neutralization of influenza virus by IgM.

Authors:  S J Armstrong; M C Outlaw; N J Dimmock
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

Review 4.  The role of scavenger receptors in pathogen recognition and innate immunity.

Authors:  Subhankar Mukhopadhyay; Siamon Gordon
Journal:  Immunobiology       Date:  2004       Impact factor: 3.144

5.  Are novel scavenger-like receptors involved in the hepatic uptake of heparin?

Authors:  Hiroaki Yuasa; Jun Watanabe
Journal:  Drug Metab Pharmacokinet       Date:  2003       Impact factor: 3.614

6.  The physiological scavenger receptor function of hepatic sinusoidal endothelial and Kupffer cells is independent of scavenger receptor class A type I and II.

Authors:  Berit Hansen; Beatriz Arteta; Bård Smedsrød
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

7.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

8.  High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype.

Authors:  I Kuhn; B Larsen; C Gross; T Hermiston
Journal:  Gene Ther       Date:  2006-10-05       Impact factor: 5.250

Review 9.  Role of Kupffer cells in host defense and liver disease.

Authors:  Manfred Bilzer; Frigga Roggel; Alexander L Gerbes
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

10.  Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5.

Authors:  Simon N Waddington; Alan L Parker; Menzo Havenga; Stuart A Nicklin; Suzanne M K Buckley; John H McVey; Andrew H Baker
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

View more
  99 in total

1.  Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.

Authors:  Jin Huk Choi; Joe Dekker; Stephen C Schafer; Jobby John; Craig E Whitfill; Christopher S Petty; Eid E Haddad; Maria A Croyle
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

2.  Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.

Authors:  Raul Alba; Angela C Bradshaw; Lynda Coughlan; Laura Denby; Robert A McDonald; Simon N Waddington; Suzanne M K Buckley; Jenny A Greig; Alan L Parker; Ashley M Miller; Hongjie Wang; Andre Lieber; Nico van Rooijen; John H McVey; Stuart A Nicklin; Andrew H Baker
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

Review 3.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

Review 4.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

5.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

6.  Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.

Authors:  Jie Tian; Zhili Xu; Jeffrey S Smith; Sean E Hofherr; Michael A Barry; Andrew P Byrnes
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

7.  Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells.

Authors:  Mari I Jonsson; Annasara E Lenman; Lars Frängsmyr; Cecilia Nyberg; Mohamed Abdullahi; Niklas Arnberg
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

8.  Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Authors:  Joseph T Bruder; Ping Chen; Elena Semenova; Charlie A Thomas; Svetlana Konovalova; Greg Ekberg; Damodar Ettyreddy; Duncan McVey; Jason G Gall; C Richter King; Douglas E Brough
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

9.  FX and host defense evasion tactics by adenovirus.

Authors:  Andrew H Baker; Stuart A Nicklin; Dmitry M Shayakhmetov
Journal:  Mol Ther       Date:  2013-06       Impact factor: 11.454

10.  Circulating antibodies and macrophages as modulators of adenovirus pharmacology.

Authors:  Reeti Khare; Matthew L Hillestad; Zhili Xu; Andrew P Byrnes; Michael A Barry
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.